SCHEMBL11896293

SCHEMBL11896293

O=C(O)[C@H](CC1CCCCCC1)NCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
MME P08473 1/20 0.51
ACE P12821 1/20 0.51
CPA1 P15085 1/20 0.51
ACE2 Q9BYF1 1/20 0.51
MMP1 P03956 5/20 0.48
FCER2 P06734 2/20 0.48
GRN P28799 1/20 0.48
SORT1 Q99523 1/20 0.48
EPHX1 P07099 1/20 0.48
HPGD P15428 1/20 0.48
KLKB1 P03952 1/20 0.47
CTSL P07711 2/20 0.47
CTSB P07858 2/20 0.47
CTSS P25774 2/20 0.47
CTSK P43235 2/20 0.47
MMP2 P08253 3/20 0.46
MMP3 P08254 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23004918 1.00 LTA4H (0.55) LTA4HNPC1RAB9AMMEACE
SCHEMBL11896295 1.00 LTA4H (0.55) LTA4HNPC1RAB9AMMEACE
SCHEMBL19974930 0.95 LTA4H (0.50) LTA4HNPC1RAB9AMMEACE
SCHEMBL23022995 0.89 MMP1 (0.56) LTA4HNPC1RAB9AMMEACE
Hydrochloric Acid SCHEMBL23005018 0.87 MMP1 (0.55) LTA4HNPC1RAB9AMMEACE
SCHEMBL23023028 0.86 KLKB1 (0.51) LTA4HNPC1RAB9AMMP1FCER2
SCHEMBL3794340 0.86 KLKB1 (0.51) LTA4HNPC1RAB9AMMP1FCER2
Hydrochloric Acid SCHEMBL23004846 0.85 KLKB1 (0.50) LTA4HNPC1RAB9AMMP1FCER2
SCHEMBL12861564 0.85 ALDH1A1 (0.42) LTA4HNPC1RAB9AMMEACE
SCHEMBL30259421 0.84 REN (0.50) LTA4HNPC1RAB9AACEMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765763-B2 Substituted piperazines as CGRP antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-01 US disclosed
US-20120196872-A1 NEW 5-ALKYNYL-PYRIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196872-A1 NEW 5-ALKYNYL-PYRIDINES CALCR, CALCRL, P2RX5 LTA4H 527/4885NPC1 2460/4885RAB9A 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.